Genpact Limited $G Shares Sold by Altrinsic Global Advisors LLC

Key Points

• Altrinsic Global Advisors LLC reduced its stake in Genpact Limited by 3.8%, selling 12,927 shares, and now owns 327,632 shares, representing 0.8% of their holdings.
• Genpact recently reported a net income of $0.88 per share for the last quarter, exceeding analysts' expectations of $0.85, and noted a 6.6% year-over-year revenue increase.
• The company declared a quarterly dividend of $0.17 per share, yielding 1.5%, with the payout ratio being 22.59% and the payment scheduled for September 25th.

Altrinsic Global Advisors LLC reduced its holdings in shares of Genpact Limited (NYSE:G - Free Report) by 3.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 327,632 shares of the business services provider's stock after selling 12,927 shares during the quarter. Genpact accounts for 0.8% of Altrinsic Global Advisors LLC's portfolio, making the stock its 18th largest position. Altrinsic Global Advisors LLC owned about 0.19% of Genpact worth $16,506,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in G. Cornerstone Planning Group LLC acquired a new position in shares of Genpact during the 1st quarter valued at $27,000. Richardson Financial Services Inc. purchased a new position in Genpact in the first quarter valued at about $35,000. SVB Wealth LLC acquired a new position in shares of Genpact during the first quarter worth about $41,000. Global X Japan Co. Ltd. purchased a new stake in shares of Genpact in the first quarter worth about $57,000. Finally, Smartleaf Asset Management LLC grew its stake in shares of Genpact by 40.8% in the first quarter. Smartleaf Asset Management LLC now owns 1,367 shares of the business services provider's stock valued at $68,000 after buying an additional 396 shares in the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.

Genpact Stock Performance

NYSE:G traded down $0.43 during trading hours on Thursday, reaching $44.98. 1,510,683 shares of the stock were exchanged, compared to its average volume of 2,134,289. Genpact Limited has a 52 week low of $37.82 and a 52 week high of $56.76. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $7.84 billion, a P/E ratio of 14.94, a P/E/G ratio of 1.56 and a beta of 0.92. The firm has a 50 day simple moving average of $44.25 and a 200-day simple moving average of $46.68.

Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.85 by $0.03. The business had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.23 billion. Genpact had a return on equity of 22.15% and a net margin of 10.92%.The business's revenue was up 6.6% compared to the same quarter last year. During the same period in the prior year, the company posted $0.79 EPS. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. As a group, sell-side analysts forecast that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Thursday, September 11th will be paid a dividend of $0.17 per share. The ex-dividend date is Thursday, September 11th. This represents a $0.68 annualized dividend and a yield of 1.5%. Genpact's dividend payout ratio is 22.59%.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. Mizuho boosted their price target on Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 1st. Wall Street Zen upgraded shares of Genpact from a "buy" rating to a "strong-buy" rating in a research note on Friday, June 6th. JPMorgan Chase & Co. decreased their target price on shares of Genpact from $55.00 to $50.00 and set a "neutral" rating for the company in a research note on Wednesday, August 20th. Needham & Company LLC lifted their price target on shares of Genpact from $50.00 to $53.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. Finally, Robert W. Baird cut their price objective on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a report on Thursday, May 8th. Three research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $52.29.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.